Abstract
Abstract
Background
Carcinoma in situ of the bladder is a high-grade cancer that originates in the superficial layer of the bladder. It has the potential to invade nearby organs, and it can spread through blood and lymphatic circulation to distant parts of the body.
Case presentation
A 58-year-old non-smoker male presented with gross and microscopic hematuria. His family history included his father’s recent bladder cancer. Initial investigations showed hematuria, inflammation, negative urine culture, digital rectal examination revealed an enlarged right lobe of the prostate, and an elevated Prostate-Specific Antigen level. Histopathological examination of samples taken from the bladder mucosa and the prostate confirmed urothelial carcinoma in situ in the bladder and prostate. Further evaluation revealed no other metastasis. The tumor was classified as T4aN0M0. The patient underwent radical cystoprostatectomy and histopathological examination showed that the tumor invading the muscularis propria of the bladder as well as the prostatic glands, but no malignancy was found in prostatic urethra and other areas. The patient was discharged three weeks post-operation and completed on adjuvant chemotherapy consisting of Gemcitabine, and Cisplatin to prevent of relapse. The patient is currently in a good healthy.
Conclusion
The occurrence of bladder cancer metastasizing to the prostate without involving the prostatic urethra is uncommon and requires precise diagnostic techniques for accurate tumor classification. Early management is advised to enhance the prognosis for the patient.
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Subiela JD, Rodríguez Faba O, Guerrero Ramos F, Vila Reyes H, Pisano F, Breda A, Palou J. Carcinoma in situ of the urinary bladder: a systematic review of current knowledge regarding detection, treatment, and outcomes. Eur Urol Focus. 2020;6(4):674–82. Epub 2019 Mar 23. PMID: 30910393.
2. Casey RG, Catto JW, Cheng L, Cookson MS, Herr H, Shariat S, Witjes JA, Black PC. Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review. Eur Urol. 2015;67(5):876–88. https://doi.org/10.1016/j.eururo.2014.10.040. Epub 2014 Nov 14. PMID: 25466937.
3. Pasin E, Josephson DY, Mitra AP, Cote RJ, Stein JP. Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol 2008 Winter;10(1):31–43. PMID: 18470273; PMCID: PMC2312342.
4. MELICOW MM. Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy. J Urol. 1952;68(1):261 – 79. https://doi.org/10.1016/S0022-5347(17)68193-X. PMID: 14939458.
5. Koutros S, Decker KL, Baris D, Pardo LA, Johnson A, Hosain GMM, Rothman N, Karagas MR, Schwenn MR, Silverman DT. Bladder cancer risk associated with family history of cancer. Int J Cancer. 2021;148(12):2915–23. https://doi.org/10.1002/ijc.33486. Epub 2021 Mar 5. PMID: 33506540; PMCID: PMC10294142.